Canadian Online Pharmacy

CDER New April 4, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

April 3, 2013


New and Generic Drug Approvals

April 2, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Azithromycin azithromycin Injectable; Injection Sun Pharm Inds Ltd Approval
Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate efavirenz; emtricitabine; tenofovir disoproxil fumarate Tablet; Oral Aurobindo Pharma Ltd Tentative Approval
Emtriva emtricitabine Capsule; Oral Gilead Labeling Revision
Emtriva emtricitabine Solution; Oral Gilead Labeling Revision
Lac-Hydrin ammonium lactate Lotion; Topical Ranbaxy Manufacturing Change or Addition
Orfadin nitisinone Capsule; Oral Rare Dis Manufacturing Change or Addition
Supprelin La histrelin acetate Implant; Subcutaneous Endo Pharm Labeling Revision
Verdeso desonide Aerosol, Foam; Topical Stiefel Labs Inc Labeling Revision
Viread tenofovir disoproxil fumarate Tablet; Oral Gilead Sciences Inc Labeling Revision
Viread tenofovir disoproxil fumarate Powder; Oral Gilead Sciences Inc Labeling Revision
Xenical orlistat Capsule; Oral Hoffmann La Roche Manufacturing Change or Addition

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery